CO-SPONSORS


ASTRO

RSNA

Highlights

  • Abstract Submission Site opens September 9.
  • Registration and Housing opens October 21.

Mark Your Calendar...

April 29-30, 2011

Atlanta Marriott Marquis
Atlanta

The Cancer Imaging and Radiation Therapy Symposium will take a multidisciplinary look at cancer staging and treatment seeking the many points of contact between imaging and radiation oncology from the day of diagnosis through the entire course of the patient’s disease.

Leaders from the world of diagnostic radiology, radiation oncology and physics will discuss cross-sectional anatomy, the distinction between tumor and normal tissue, image modality selection and target definition, as well as new developments in brachytherapy, IGRT and 4-D therapy. The future of biological imaging and adaptive therapy will be addressed from the perspective of both specialties.


Needs Statement

The practice of radiation oncology was founded and has developed on a solid base of medical imaging. As imaging improves, so does radiation therapy. Loco-regional control remains essential for the cure of the majority of malignant tumors. Increasing radiation dose increases the chance for cure but carries risks of serious toxicity. New radiation delivery systems allows for the delivery of radiation with much greater conformality than ever before but, without good definition of the tumor target this advantages is squandered.

The radiation oncologist must, therefore, understand better the interpretation of contemporary radiographic images and understand better the additional value from new imaging modalities. The radiologist on the other hand needs to better understand the needs of radiation oncologist in defining target volumes for advanced radiation techniques.


Program Objectives

  • Distinguish malignant from normal tissue by selecting the correct imaging study.
  • Recognize cross-sectional normal anatomy of different body sites for various diagnostic imaging modalities.
  • Select and use diagnostic imaging studies to best define radiation target volumes.
  • Increase the interaction between radiation therapy and imaging as it relates to brachytherapy, IMRT, IGRT, 4-D therapy and SBRT.
  • Discover the concept of biologic imaging and update the audience on various types of physiologic and metabolic imaging with an emphasis on current and future applications in oncology.
  • Evaluate tumor response to treatment, assess for recurrence and plan re-treatment.

Target Audience

The meeting is designed for practicing radiation oncologists, practicing diagnostic radiologists, residents in training, fellows and medical physicists.